Literature DB >> 8984892

Characterization of benzodiazepine "combinatorial" chemical libraries by on-line immunoaffinity extraction, coupled column HPLC-ion spray mass spectrometry-tandem mass spectrometry.

M L Nedved1, S Habibi-Goudarzi, B Ganem, J D Henion.   

Abstract

To characterize combinatorial chemical libraries of small drug compounds, an automated column switching system incorporating an immunoaffinity extraction (IAE) column and two reversed-phase HPLC columns was coupled to a triple-quadrupole mass spectrometer. A Protein G column and antibodies to benzodiazepines were used to screen library components. A pH change in the mobile phase eluted the benzodiazepine-antibody complexes onto a C-18 restricted access media (RAM) column, thereby separating the selected benzodiazepines from the antibody. In a final step, backflushing the RAM column eluted the benzodiazepines onto a C-8 analytical reversed-phase column for separation before detection and preliminary structural characterization using ion spray mass spectrometry (MS) and tandem mass spectrometry (MS/ MS). A known 19-component library and an unknown 20-component library were analyzed. Full-scan IAE/LC/ LC/MS and IAE/LC/LC/MS/MS chromatograms suggested the feasibility of this combination of techniques, although the antibodies used were not highly specific. Inspection of MS/MS spectra of components in the unknown library compared to the MS/MS spectrum of a known standard (chlordiazepoxide) identified a subclass of benzodiazepines. Productions of the known standard and an unknown benzodiazepine were successively captured and fragmented (MSn experiments) using an iontrap mass spectrometer off-line, which confirmed that the unknown was an analogue of chlordiazepoxide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8984892     DOI: 10.1021/ac9603035

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Mass spectrometry and immobilized enzymes for the screening of inhibitor libraries.

Authors:  M T Cancilla; M D Leavell; J Chow; J A Leary
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  Mass spectrometry innovations in drug discovery and development.

Authors:  D I Papac; Z Shahrokh
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

3.  Mass spectrometry and non-covalent protein-ligand complexes: confirmation of binding sites and changes in tertiary structure.

Authors:  Sharon J Shields; Olayinka Oyeyemi; Felice C Lightstone; Rod Balhorn
Journal:  J Am Soc Mass Spectrom       Date:  2003-05       Impact factor: 3.109

4.  Multidimensional chromatography coupled with mass spectrometry for target-based screening.

Authors:  Y F Hsieh; N Gordon; F Regnier; N Afeyan; S A Martin; G J Vella
Journal:  Mol Divers       Date:  1997       Impact factor: 2.943

5.  Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry.

Authors:  Frederick G Strathmann; Thomas J Laha; Andrew N Hoofnagle
Journal:  Clin Chem       Date:  2011-07-18       Impact factor: 8.327

6.  The rapid hydrolysis of chlordiazepoxide to demoxepam may affect the outcome of chronic osmotic minipump studies.

Authors:  Christiaan H Vinkers; Gerdien A H Korte-Bouws; Javier Sastre Toraño; Naheed R Mirza; Elsebet Ø Nielsen; Philip K Ahring; Gerhardus J de Jong; Berend Olivier
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.